Tactile Systems Technology (TCMD) Net Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148.36% |
| Dec 31, 2025 | 212.32% |
| Sep 30, 2025 | -644.29% |
| Jun 30, 2025 | 80.55% |
| Mar 31, 2025 | -187.95% |
| Dec 31, 2024 | 43.30% |
| Sep 30, 2024 | -33.95% |
| Jun 30, 2024 | 4,048.62% |
| Mar 31, 2024 | 93.46% |
| Dec 31, 2023 | -277.16% |
| Sep 30, 2023 | -65.57% |
| Jun 30, 2023 | -75.21% |
| Mar 31, 2023 | 2,309.89% |
| Dec 31, 2022 | -2,069.74% |
| Sep 30, 2022 | -96.55% |
| Jun 30, 2022 | 131.08% |
| Mar 31, 2022 | -221.47% |
| Dec 31, 2021 | 121.90% |
| Sep 30, 2021 | -1,377.91% |
| Jun 30, 2021 | 323.87% |
| Mar 31, 2021 | -116.46% |
| Dec 31, 2020 | -47.98% |
| Sep 30, 2020 | 1,236.30% |
| Jun 30, 2020 | -110.03% |
| Mar 31, 2020 | 222.29% |
| Dec 31, 2019 | 156.56% |
| Sep 30, 2019 | -450.27% |
| Jun 30, 2019 | -56.74% |
| Mar 31, 2019 | 213.57% |
| Dec 31, 2018 | -152.22% |
| Sep 30, 2018 | 172.76% |
| Jun 30, 2018 | -694.28% |
| Mar 31, 2018 | -68.83% |
| Dec 31, 2017 | 177.14% |
| Sep 30, 2017 | 159.47% |
| Jun 30, 2017 | 73.79% |
| Mar 31, 2017 | -16.22% |
| Dec 31, 2016 | -126.38% |
| Sep 30, 2016 | 3,395.17% |
| Jun 30, 2016 | 173.21% |
| Mar 31, 2016 | -191.71% |
| Dec 31, 2015 | 156.09% |